Literature DB >> 212144

Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis.

M A Lutzner.   

Abstract

EV is an autosomal recessive disease which usually begins in infancy or childhood, with an average age of onset of 9. Flat warts are most common, but pityriasis-like warts occur in approximately 75% of patients. Warts are disseminated and chronic. Cancer may develop as early as age 13; the average age of onset is 31. About 1/3 rd. of patients develop cancer of the skin usually multiple and in light-exposed areas. It may take only two years from wart to cancer, or many more years. The cancer is carcinoma-in-situ of the Bowenoid type or squamous cell carcinoma. Two deaths have occured by local invasion and only one metastasis has been reported. One patient died of Burkitt's lymphoma and another was reported to have disseminated reticulosis. 8% of the patients are mentally retarded. Humoral immunity is normal; cell mediated immunity is depressed in most patients. The gene defect in EV has not yet been uncovered.

Entities:  

Mesh:

Year:  1978        PMID: 212144

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  29 in total

Review 1.  Role of papillomaviruses.

Authors:  F Chang
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

Review 2.  Epidermodysplasia verruciformis in an HIV-infected man: a case report and review of the literature.

Authors:  Amit Kaushal; Shane Silver; Ken Kasper; Alberto Severini; Sate Hamza; Yoav Keynan
Journal:  Top Antivir Med       Date:  2012-12

3.  The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study.

Authors:  Roel E Genders; Hadi Mazlom; Angelika Michel; Elsemieke I Plasmeijer; Koen D Quint; Michael Pawlita; Els van der Meijden; Tim Waterboer; Hans de Fijter; Frans H Claas; Ron Wolterbeek; Mariet C W Feltkamp; Jan Nico Bouwes Bavinck
Journal:  J Invest Dermatol       Date:  2014-10-27       Impact factor: 8.551

Review 4.  Roots and perspectives of contemporary papillomavirus research.

Authors:  H zur Hausen
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  Demonstration of human papilloma virus type 2 DNA in Bowen's disease.

Authors:  H Pfister; E Haneke
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

Review 6.  Warts and all: human papillomavirus in primary immunodeficiencies.

Authors:  Jennifer W Leiding; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

7.  EVER2 deficiency is associated with mild T-cell abnormalities.

Authors:  Amandine Crequer; Capucine Picard; Vincent Pedergnana; Annick Lim; Shen-Ying Zhang; Laurent Abel; Slawomir Majewski; Jean-Laurent Casanova; Stefania Jablonska; Gerard Orth; Emmanuelle Jouanguy
Journal:  J Clin Immunol       Date:  2012-08-19       Impact factor: 8.317

8.  Epidermodysplasia verruciformis induced by a new human papillomavirus (HPV-8). Report of a case without immune dysfunction. Effect of treatment with an aromatic retinoid.

Authors:  A L Claudy; J L Touraine; D Mitanne
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

9.  Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation.

Authors:  David F McDermott; Bryan Gammon; Peter J Snijders; Ihunanya Mbata; Beth Phifer; A Howland Hartley; Chyi-Chia Richard Lee; Philip M Murphy; Sam T Hwang
Journal:  Pediatr Dermatol       Date:  2009 May-Jun       Impact factor: 1.588

10.  Biochemical characterization of two types of human papillomaviruses associated with epidermodysplasia verruciformis.

Authors:  D Kremsdorf; S Jablonska; M Favre; G Orth
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.